THE CLINICAL DEVELOPMENT OF CARFILZOMIB
Carfilzomib is a second-generation proteasome inhibitor that is being investigated as a potential treatment for patients .
THE CLINICAL DEVELOPMENT OF CARFILZOMIB
Industry:
Biotechnology Health Care
Founded:
1992-01-01
Address:
South San Francisco, California, United States
Country:
United States
Website Url:
http://www.onyx.com
Total Employee:
10001+
Status:
Active
Contact:
6502660784
Email Addresses:
[email protected]
Technology used in webpage:
Domain Not Resolving IPv6 Microsoft CPanel SSL MailChimp CPanel OVH Apple Whitelist
Official Site Inspections
http://www.onyx.com
- Host name: 185.158.133.1
- IP address: 185.158.133.1
- Location: Germany
- Latitude: 51.2993
- Longitude: 9.491
- Timezone: Europe/Berlin
Loading ... 